These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 27459249

  • 1. Short-term follow-up MRI after unplanned resection of malignant soft-tissue tumours; quantitative measurements on dynamic contrast enhanced and diffusion-weighted MR images.
    Kim JI, Lee IS, Song YS, Park SK, Choi KU, Song JW.
    Br J Radiol; 2016 Oct; 89(1066):20160302. PubMed ID: 27459249
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
    Choi YJ, Lee IS, Song YS, Kim JI, Choi KU, Song JW.
    J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
    [Abstract] [Full Text] [Related]

  • 3. Analyses of short-term follow-up MRI and PET-CT for evaluation of residual tumour after inadequate primary resection of malignant soft-tissue tumours.
    Choi YY, Lee IS, Kim SJ, Kim JI, Choi KU, Lee JW, Song JW, Moon TY.
    Clin Radiol; 2013 Feb; 68(2):117-24. PubMed ID: 22795944
    [Abstract] [Full Text] [Related]

  • 4. Dynamic contrast-enhanced and diffusion-weighted MR imaging in the characterisation of small, non-palpable solid testicular tumours.
    Manganaro L, Saldari M, Pozza C, Vinci V, Gianfrilli D, Greco E, Franco G, Sergi ME, Scialpi M, Catalano C, Isidori AM.
    Eur Radiol; 2018 Feb; 28(2):554-564. PubMed ID: 28856410
    [Abstract] [Full Text] [Related]

  • 5. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
    Meyer HJ, Leifels L, Schob S, Garnov N, Surov A.
    Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of diffusion-weighted MR imaging for differentiating between benign and malignant superficial soft tissue tumours and tumour-like lesions.
    Jeon JY, Chung HW, Lee MH, Lee SH, Shin MJ.
    Br J Radiol; 2016 Jan; 89(1060):20150929. PubMed ID: 26892266
    [Abstract] [Full Text] [Related]

  • 7. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses.
    Xu XQ, Qian W, Ma G, Hu H, Su GY, Liu H, Shi HB, Wu FY.
    Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096
    [Abstract] [Full Text] [Related]

  • 8. Multiparametric quantitative analysis of tumor perfusion and diffusion with 3T MRI: differentiation between benign and malignant soft tissue tumors.
    Lee SK, Jee WH, Jung CK, Chung YG.
    Br J Radiol; 2020 Nov 01; 93(1115):20191035. PubMed ID: 32649224
    [Abstract] [Full Text] [Related]

  • 9. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
    Oh E, Yoon YC, Kim JH, Kim K.
    Clin Radiol; 2017 Jul 01; 72(7):552-559. PubMed ID: 28325514
    [Abstract] [Full Text] [Related]

  • 10. Post-treatment complications of soft tissue tumours.
    Shapeero LG, De Visschere PJ, Verstraete KL, Poffyn B, Forsyth R, Sys G, Uyttendaele D.
    Eur J Radiol; 2009 Feb 01; 69(2):209-21. PubMed ID: 19101106
    [Abstract] [Full Text] [Related]

  • 11. Differentiation of malignant from benign soft tissue tumours: use of additive qualitative and quantitative diffusion-weighted MR imaging to standard MR imaging at 3.0 T.
    Lee SY, Jee WH, Jung JY, Park MY, Kim SK, Jung CK, Chung YG.
    Eur Radiol; 2016 Mar 01; 26(3):743-54. PubMed ID: 26080796
    [Abstract] [Full Text] [Related]

  • 12. Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancer.
    Chung MP, Margolis D, Mesko S, Wang J, Kupelian P, Kamrava M.
    J Med Imaging Radiat Oncol; 2014 Oct 01; 58(5):588-94. PubMed ID: 25196228
    [Abstract] [Full Text] [Related]

  • 13. Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.
    Anzidei M, Napoli A, Sacconi B, Boni F, Noce V, Di Martino M, Saba L, Catalano C.
    Radiol Med; 2016 Dec 01; 121(12):905-915. PubMed ID: 27567615
    [Abstract] [Full Text] [Related]

  • 14. Differential diagnosis of parotid gland tumours: Application of SWI combined with DWI and DCE-MRI.
    Xu Z, Chen M, Zheng S, Chen S, Xiao J, Hu Z, Lu L, Yang Z, Lin D.
    Eur J Radiol; 2022 Jan 01; 146():110094. PubMed ID: 34906852
    [Abstract] [Full Text] [Related]

  • 15. Relationship between diffusion parameters derived from intravoxel incoherent motion MRI and perfusion measured by dynamic contrast-enhanced MRI of soft tissue tumors.
    Marzi S, Stefanetti L, Sperati F, Anelli V.
    NMR Biomed; 2016 Jan 01; 29(1):6-14. PubMed ID: 26602061
    [Abstract] [Full Text] [Related]

  • 16. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging.
    Ahn SS, Shin NY, Chang JH, Kim SH, Kim EH, Kim DW, Lee SK.
    J Neurosurg; 2014 Aug 01; 121(2):367-73. PubMed ID: 24949678
    [Abstract] [Full Text] [Related]

  • 17. Characterization of orbital masses by multiparametric MRI.
    Ro SR, Asbach P, Siebert E, Bertelmann E, Hamm B, Erb-Eigner K.
    Eur J Radiol; 2016 Feb 01; 85(2):324-36. PubMed ID: 26781137
    [Abstract] [Full Text] [Related]

  • 18. The value of combining conventional, diffusion-weighted and dynamic contrast-enhanced MR imaging for the diagnosis of parotid gland tumours.
    Tao X, Yang G, Wang P, Wu Y, Zhu W, Shi H, Gong X, Gao W, Yu Q.
    Dentomaxillofac Radiol; 2017 Aug 01; 46(6):20160434. PubMed ID: 28299943
    [Abstract] [Full Text] [Related]

  • 19. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
    Li X, Abramson RG, Arlinghaus LR, Kang H, Chakravarthy AB, Abramson VG, Farley J, Mayer IA, Kelley MC, Meszoely IM, Means-Powell J, Grau AM, Sanders M, Yankeelov TE.
    Invest Radiol; 2015 Apr 01; 50(4):195-204. PubMed ID: 25360603
    [Abstract] [Full Text] [Related]

  • 20. Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study.
    Jalaguier-Coudray A, Villard-Mahjoub R, Delouche A, Delarbre B, Lambaudie E, Houvenaeghel G, Minsat M, Tallet A, Sabatier R, Thomassin-Naggara I.
    Radiology; 2017 Aug 01; 284(2):432-442. PubMed ID: 28301309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.